Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Appl Toxicol ; 30(2): 172-82, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19839026

ABSTRACT

Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi-age rat model could be used for pre-clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age-dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague-Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg(-1) i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were >or= 25 days old. Several serum, urinary and 'omic' injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age-related Cis-induced nephrotoxicity was different than our previous study with gentamicin: 80 > 40 > 10 > 25 day-old vs 10 >or= 80 > 40 > 25-day-old rats, respectively. The increased levels of kidney injury molecule-1 (Kim-1: urinary protein/tissue mRNA) provided evidence of early Cis-induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim-1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi-age rat model can be used to demonstrate different age-related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers.


Subject(s)
Aging/physiology , Cisplatin/toxicity , Kidney Diseases/chemically induced , Kidney/metabolism , Age Factors , Animals , Biomarkers/metabolism , Biomarkers/urine , Child , Disease Susceptibility/metabolism , Disease Susceptibility/pathology , Gentamicins/toxicity , Humans , Kidney/pathology , Kidney Diseases/pathology , Kidney Diseases/urine , Models, Animal , Pediatrics , Rats , Rats, Sprague-Dawley , Sensitivity and Specificity
2.
J Food Sci ; 72(2): C120-5, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17995826

ABSTRACT

Kava (Piper methysticum) extract products have been implicated in a number of severe hepatotoxicity cases. However, systematic toxicological studies regarding kava consumption have not been reported. In this study, 6 major kavalactones and different solvent fractions of kava roots, leaves, and stem peelings were evaluated for their mutagenic potential. None of the kavalactones was found to be positive in the experimental concentration ranges tested by the umu test (a sensitive test for point mutations). However, among the different solvent fractions, the n-butanol fraction of kava leaves was positive. Further investigations using bioassay-directed isolation and analysis indicated that 2 C-glycoside flavonoid compounds accounted for the positive mutagenic results. Two isolated compounds were identified as 2''-O-rhamnosylvitexin and schaftoside by NMR and MS techniques.


Subject(s)
Flavonoids/toxicity , Kava/chemistry , Monosaccharides/toxicity , Mutagenicity Tests , Plant Extracts/toxicity , Animals , Biological Assay , Chemical and Drug Induced Liver Injury , Flavonoids/isolation & purification , Glycosides , Monosaccharides/isolation & purification , Plant Leaves/chemistry , Plant Roots/chemistry , Plant Stems/chemistry , Point Mutation , Rats , Rats, Sprague-Dawley , Salmonella typhimurium/drug effects
3.
Kidney Int ; 69(12): 2194-204, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16672910

ABSTRACT

We have shown that cisplatin inhibits fatty acid oxidation, and that fibrate treatment ameliorates renal function by preventing the inhibition of fatty acid oxidation and proximal tubule cell death. Urine samples of mice treated with single injection of cisplatin (20 mg/kg body weight) were collected for 3 days and analyzed by 1H-nuclear magnetic resonance (NMR) spectroscopy. In a separate group, urine samples of mice treated with peroxisome proliferator-activated receptor-alpha (PPARalpha) ligand WY were also analyzed by NMR after 2 days of cisplatin exposure. Biochemical analysis of endogenous metabolites was performed in serum, urine, and kidney tissue. Electron microscopic studies were carried out to examine the effects of PPARalpha ligand and cisplatin. Principal component analysis demonstrated the presence of glucose, amino acids, and trichloacetic acid cycle metabolites in the urine after 48 h of cisplatin administration. These metabolic alterations precede changes in serum creatinine. Biochemical studies confirmed the presence of glucosuria, but also demonstrated the accumulation of nonesterified fatty acids, and triglycerides in serum, urine, and kidney tissue, in spite of increased levels of plasma insulin. These metabolic alterations were ameliorated by the use of PPARalpha ligand. Electron microscopic analysis confirmed the protective effect of the fibrate on preventing cisplatin-mediated necrosis of the S3 segment of the proximal tubule. Our study shows that cisplatin-induces a unique NMR metabolic profile in urine of mice that developed acute renal failure, and confirms the protective effect of a fibrate class of PPARalpha ligands. We propose that the injury-induced metabolic profile may be used as a biomarker of cisplatin-induced nephrotoxicity.


Subject(s)
Acute Kidney Injury/metabolism , Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Kidney/drug effects , Kidney/metabolism , Acute Kidney Injury/chemically induced , Acute Kidney Injury/pathology , Acute Kidney Injury/prevention & control , Animals , Antineoplastic Agents/toxicity , Cisplatin/toxicity , Clofibric Acid/pharmacology , Fanconi Syndrome/chemically induced , Fanconi Syndrome/metabolism , Fanconi Syndrome/pathology , Fatty Acids, Nonesterified/analysis , Fatty Acids, Nonesterified/blood , Fatty Acids, Nonesterified/urine , Glucose/analysis , Glucose/metabolism , Hyperglycemia/chemically induced , Hyperglycemia/metabolism , Hyperglycemia/pathology , Hyperglycemia/prevention & control , Insulin/blood , Kidney/chemistry , Kidney/ultrastructure , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/metabolism , Kidney Tubules, Proximal/ultrastructure , Magnetic Resonance Spectroscopy , Male , Mice , Mice, Inbred Strains , Microscopy, Electron , PPAR alpha/pharmacology , Triglycerides/analysis , Triglycerides/blood
4.
Exp Clin Immunogenet ; 14(4): 235-42, 1997.
Article in English | MEDLINE | ID: mdl-9523159

ABSTRACT

Fc gamma receptors (Fc gamma R) on white blood cells and the Duffy blood group antigens on red blood cells are coded for on the long arm of chromosome 1. They appear in different allotypic forms: the high responder/low responder (HR/LR) forms of Fc gamma RIIa, the alloantigens NA1 and NA2 of Fc gamma RIIIb and the Duffy blood group antigens Fya and Fyb. The aim of this study was to analyze possible linkage disequilibria between these allotypic immunomodulatory receptors, and thus provide evidence for the existence of a hypothetical gene complex. The Duffy phenotype was determined by the indirect antiglobulin test, NA1/NA2 phenotypes by the granulocyte agglutination test and the HR/LR polymorphism by an immunophagocytosis assay. Two haplotypes were found to be in linkage disequilibrium. For the haplotype NA2, Fyb we calculated a delta-value of -0.07 and for the haplotype NA1, HR we obtained a delta-value of -0.02.


Subject(s)
Antigens, CD/genetics , Duffy Blood-Group System/genetics , Linkage Disequilibrium , Receptors, IgG/genetics , Erythrocytes/chemistry , Gene Frequency , Haplotypes , Humans , Monocytes/chemistry , Neutrophils/chemistry , Phagocytosis , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL